Eyenovia, Inc. is a clinical stage ophthalmic biopharmaceutical company based in New York, New York. They are focused on developing a pipeline of advanced therapeutics for ophthalmic conditions. Eyenovia is known for their proprietary microdose array technology and the development of the Optejet® device, which is designed to deliver minimal amounts of medication to the eye. With a commitment to maintaining efficacy, Eyenovia aims to provide innovative solutions for ophthalmic treatments.

Eyenovia, Inc., New York, New York. 171 likes · 5 were here. Eyenovia is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of...

Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its proprietary microdose array ...

Eyenovia, Inc. (NASDAQ: EYEN), is an ophthalmic technology company developing the Optejet® device for use both in connection with its own drug-device ...

Eyenovia, Inc.

Find contacts at this company